The Outpatient Bleeding Risk Index (OBRI) estimates risk of bleeding in AF while on oral anticoagulation.
The use of oral anticoagulation is associated with an increased risk of minor (non-life threatening) and major (potentially life threatening) bleeding. Knowledge of the risk of major bleeding with warfarin therapy, as estimated by the Outpatient Bleeding Risk Index (OBRI), could help guide anticoagulation therapy. For example, if a patient with atrial fibrillation has a high risk of major bleeding and a low risk of stroke then anticoagulation may be harmful.
Aspinall SL, DeSanzo BE, Trilli LE, et al.
The use of oral anticoagulation is associated with an increased risk of minor (non-life threatening) and major (potentially life threatening) bleeding. Knowledge of the risk of major bleeding with warfarin therapy, as estimated by the Outpatient Bleeding Risk Index (OBRI), could help guide anticoagulation therapy. For example, if a patient with atrial fibrillation has a high risk of major bleeding and a low risk of stroke then anticoagulation may be harmful.
Aspinall SL, DeSanzo BE, Trilli LE, et al.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
